Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Acquisition

1 Aug 2022 07:01

RNS Number : 3477U
JLEN Environmental Assets Group Ltd
01 August 2022
 

1 August 2022

 

JLEN Environmental Assets Group Limited

("JLEN" or the "Company")

 

Investment in a controlled environment aquaculture project

JLEN, the listed environmental infrastructure fund, is pleased to announce that it has reached financial close on a minority equity investment in a controlled environment aquaculture project. 

The equity investment will be made alongside other Foresight funds, as well as the developer and operator of the facility, Hima Seafood AS. JLEN's total investment is expected to be up to approximately £40m over the next three to four years.

The project consists of a land-based aquaculture facility to be built in Rjukan, Norway, and will use established recirculating aquaculture system ("RAS") technology. It is expected that partial operations will commence in 2024 with full operations expected in 2025, following which, the facility is forecasted to produce approximately 8,000 tonnes of trout annually. This will be sold to European and international salmonid markets via an offtake agreement with an established Norwegian seafood distribution company with global reach.

Driven by a growing global population and an expanding middle class, the world faces an increasing demand for quality protein amid limited resources of usable land and water. Recent data shows that 34.8%1 of global animal protein production comes from fish and seafood sources and the fish and seafood market grew between 4% - 8% annually in the ten-year period to 20191. 

Global demand for animal protein is projected to double by 20502. Fish, including salmonids such as salmon and trout, is considered one of the most efficient sources of high-quality animal protein due to the rate at which it converts feed into edible mass, its high protein retention and high rate of edible meat per kilogram, as well as various nutritional benefits. Land-based aquaculture, such as the RAS based facility to be built in Rjukan, can provide a range of benefits compared with alternative methods of aquaculture such as improved fish mortality rates, less local environmental degradation and a lower use of antibiotics and other chemicals to control disease and parasites.

 

Richard Ramsay, Senior Independent Director of JLEN, said:

 

"We are pleased to make our first investment into land-based aquaculture, contributing to the sustainable supply of trout to meet rising consumer demand. We consider that this investment will deliver environmental benefits to the food system and offer a product to suit today's consumer needs."

1) Source: United Nations FAO, FAOSTAT Statistical Database

2) Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532560/#B2-foods-06-00053

 

For further information and enquiries, please contact:

 

Foresight Group

Chris Tanner

Chris Holmes

 

+44 (0)20 3667 8100

Winterflood Investment Trusts

Neil Langford

Chris Mills

 

+44 (0)20 3100 0000

SEC Newgate (For media enquiries)

Elisabeth Cowell

+44 (0)20 3757 6882

jlen@secnewgate.co.uk

 

Sanne Fund Services (Guernsey) Limited

Matt Falla

Gemma Woods

+44 (0)14 8175 5530

 

About JLEN

JLEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

- long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

- long-term contracts or stable and well-proven regulatory and legal frameworks; or

- well-established technologies, and demonstrable operational performance.

JLEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2023 is 7.14 pence per share1. The dividend is payable quarterly.

Further details of the Company can be found on its website www.jlen.com

LEI: 213800JWJN54TFBMBI68

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRBMFTMTAJBIT
Date   Source Headline
12th Aug 20164:09 pmRNSIssue of Equity
8th Aug 20161:08 pmRNSHolding(s) in Company
4th Aug 20165:02 pmRNSIssue of Equity
2nd Aug 201611:48 amRNSBlocklisting Application
29th Jul 20162:10 pmRNSIssue of Equity
28th Jul 201610:42 amRNSIssue of Equity
22nd Jul 20167:00 amRNSAcquisition and Credit Facility Extension
4th Jul 20164:00 pmRNSNotice of AGM
30th Jun 20167:00 amRNSAcquisition
22nd Jun 20162:00 pmRNSManagement Services Agreements
17th Jun 20167:00 amRNSAnnual Financial Report
3rd Jun 201610:52 amRNSHolding(s) in Company
27th May 20167:00 amRNSResult of Placing
12th May 20167:00 amRNSNet Asset Value, Dividend and Issue Price
11th May 20167:00 amRNSAcquisition
21st Apr 20167:00 amRNSProposed Equity Issue
17th Mar 20167:00 amRNSAcquisition
23rd Feb 20167:00 amRNSDividend Timetable and Home Member State
18th Feb 20167:00 amRNSNet Asset Value and Dividend
2nd Dec 201512:52 pmRNSAcquisition
1st Dec 20155:37 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSDirector/PDMR Shareholding
20th Nov 20155:00 pmRNSFCA Listing Rules
19th Nov 20156:30 pmRNSHalf Yearly Report
17th Nov 20157:00 amRNSAcquisition of Solar PV Portfolio
2nd Nov 20157:00 amRNSAcquisition of Solar PV Portfolio
14th Aug 20157:00 amRNSNet Asset Value(s)
13th Aug 20153:00 pmRNSResult of AGM
4th Aug 201512:51 pmRNSHolding(s) in Company (Replacement)
4th Aug 201512:30 pmRNSHolding(s) in Company
3rd Aug 20157:00 amRNSTotal Voting Rights
31st Jul 20151:00 pmRNSSolar Acquisitions
23rd Jul 20154:57 pmRNSResponse to DECC Press Release
17th Jul 20154:45 pmRNSNotice of AGM
15th Jul 20158:30 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSResults of Issue
9th Jul 20157:00 amRNSBudget Response
6th Jul 201510:22 amRNSResult of EGM
29th Jun 20157:00 amRNSMailing of Annual Report and letter
4th Jun 20155:25 pmRNSPublication of Prospectus
4th Jun 20157:00 amRNSEquity Raise and Issue Price
4th Jun 20157:00 amRNSAnnual Financial Report
20th May 20157:00 amRNSEquity Raise & Placing Programme
20th Apr 20152:00 pmRNSDividend and Possible Equity Fund-raising
1st Apr 201511:24 amRNSAcquisition - Replacement
1st Apr 20157:00 amRNSAcquisition
17th Feb 20154:50 pmRNSHolding(s) in Company
17th Feb 20154:50 pmRNSHolding(s) in Company
17th Feb 20154:50 pmRNSHolding(s) in Company
17th Feb 20154:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.